Sotac Pharmaceuticals Limited (NSE:SOTAC)

India · Delayed Price · Currency is INR

90.05

0.00 (0.00%)

Oct 1, 2026, 2:34 PM IST

Sotac Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	1,013	1,013	999.29	1,039	774.83	731.52
Revenue Growth	24.01%	1.33%	-3.80%	34.07%	5.92%	49.77%
Gross Profit	365.58	365.58	314.22	242.69	202.14	171.75
Operating Income	126.35	126.35	131.33	57.2	53.13	68.51
Net Income	57.67	57.67	80.27	42.81	28.79	28.79
Earnings Per Share	5.22	5.22	7.26	3.90	3.58	3.58
EPS Growth	-32.56%	-28.12%	86.15%	9.04%	0.02%	-

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	11.78	11.78	20.23	38.51	100.94	0.28
Total Debt	375.97	375.97	436.99	248.59	220.39	73.88
Net Cash (Debt)	-364.19	-364.19	-416.76	-210.08	-119.45	-73.6
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-32.96	-32.96	-37.72	-19.14	-14.84	-9.14

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	168.53	168.53	-43.5	-160.76	81.43	63.51
Capital Expenditures	-78.94	-78.94	-170.16	-177.89	-90	-35.04
Free Cash Flow	89.59	89.59	-213.66	-338.65	-8.57	28.46
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	36.10%	36.10%	31.44%	23.36%	26.09%	23.48%
Operating Margin	12.48%	12.48%	13.14%	5.51%	6.86%	9.37%
Pretax Margin	8.59%	8.59%	11.13%	3.82%	5.07%	6.42%
Profit Margin	5.70%	5.70%	8.03%	4.12%	3.72%	3.94%
FCF Margin	8.85%	8.85%	-21.38%	-32.60%	-1.11%	3.89%

Dividends

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 7, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Dividend Per Share	0.200	0.200	0.100	-	-	2.000
Dividend Per Share Growth	0%	100.00%	-	-	-	-
Dividend Yield	0.22%	0.18%	0.08%	-	-	-

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 7, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	17.26	20.93	16.35	31.23	-	-
P/FCF Ratio	11.11	13.48	-	-	-	-
PS Ratio	0.98	1.19	1.31	1.29	-	-